Imunon, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
IMNN on Nasdaq
Industry
Pharmaceutical Preparations
Location
997 Lenox Drive, Suite 100, Lawrenceville, NJ

Insiders trading volume in the past year

Imunon, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael H. Tardugno Executive Chairman of Board, Director $364K +$25.8K +7.61% Sep 10, 2024
Stacy Lindborg President and CEO, Director $259K +$24.5K +10.5% Sep 10, 2024
Constantine J. Kardaras Chief Accounting Officer $57.4K Jun 13, 2022
Corinne Le Goff President and CEO, Director $51.9K Mar 17, 2023
Sebastien Hazard Chief Medical Officer $19.6K Dec 7, 2023
Robert W. Hooper Director $12.3K Jun 13, 2022
Timothy J. Tumminello Controller Jun 13, 2022
Frederick J. Fritz Director Sep 10, 2024
Jeffrey Wayne Church Cfo Mar 15, 2024
Khursheed Anwer Chief Scientific Officer Sep 10, 2024
Christine A. Pellizzari Director Sep 10, 2024
James E. Dentzer Director Sep 10, 2024
David Gaiero Chief Financial Officer Jun 1, 2024
Pok Yu Augustine Chow Director Mar 17, 2023
Donald P. Braun Director Sep 10, 2024

Recent Insider Transactions by Companies or Individuals for Imunon, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.